Introducing concierge-level access to accelerated, mobile AMPA TMS treatment for patients seeking innovative, physician-directed mental health care. Mental health care should be accessible, innovative ...
Ampa has raised $8.5m and initiated the US rollout of its transcranial magnetic stimulation (TMS) system for treating major depressive disorder (MDD), months after emerging from stealth. The US-based ...
SARASOTA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. ("HOPE"), an interventional psychiatry network owned by NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) today announced initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback